Clinical trial
DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect
NCT00424905 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00424905 |
|---|---|
| Title | DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect |
| Official title | Evaluation of the Effects of Enterogermina, 2 Billion Bacillus Clausii Spores, on the Intestinal Flora of Children Antibiotic Treated for Bacterial Upper Respiratory Tract Infections: Open, Pilot Study. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastrointestinal Diseases |
| Intervention type | Drug |
| Interventions | Bacillus clausii |
| Enrollment | 60 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Dec 1, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: